471 related articles for article (PubMed ID: 30276612)
1. Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention.
Ao LY; Yan YY; Zhou L; Li CY; Li WT; Fang WR; Li YM
J Mol Neurosci; 2018 Nov; 66(3):342-355. PubMed ID: 30276612
[TBL] [Abstract][Full Text] [Related]
2. New Insight Into Neutrophils: A Potential Therapeutic Target for Cerebral Ischemia.
Chen R; Zhang X; Gu L; Zhu H; Zhong Y; Ye Y; Xiong X; Jian Z
Front Immunol; 2021; 12():692061. PubMed ID: 34335600
[TBL] [Abstract][Full Text] [Related]
3. Glia-immune interactions post-ischemic stroke and potential therapies.
Hersh J; Yang SH
Exp Biol Med (Maywood); 2018 Dec; 243(17-18):1302-1312. PubMed ID: 30537868
[TBL] [Abstract][Full Text] [Related]
4. Adaptive Immunity Regulation and Cerebral Ischemia.
Qin X; Akter F; Qin L; Cheng J; Guo M; Yao S; Jian Z; Liu R; Wu S
Front Immunol; 2020; 11():689. PubMed ID: 32477327
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity in acute ischemic stroke and the role of blood-brain barrier: the dark side or the light one?
Tsygan NV; Trashkov AP; Litvinenko IV; Yakovleva VA; Ryabtsev AV; Vasiliev AG; Churilov LP
Front Med; 2019 Aug; 13(4):420-426. PubMed ID: 30929189
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain barrier dysfunction and recovery after ischemic stroke.
Jiang X; Andjelkovic AV; Zhu L; Yang T; Bennett MVL; Chen J; Keep RF; Shi Y
Prog Neurobiol; 2018; 163-164():144-171. PubMed ID: 28987927
[TBL] [Abstract][Full Text] [Related]
7. NG2-glia cell proliferation and differentiation by glial growth factor 2 (GGF2), a strategy to promote functional recovery after ischemic stroke.
Li F; Liu WC; Wang Q; Sun Y; Wang H; Jin X
Biochem Pharmacol; 2020 Jan; 171():113720. PubMed ID: 31751533
[TBL] [Abstract][Full Text] [Related]
8. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
[TBL] [Abstract][Full Text] [Related]
9. Pivotal role of innate myeloid cells in cerebral post-ischemic sterile inflammation.
Tsuyama J; Nakamura A; Ooboshi H; Yoshimura A; Shichita T
Semin Immunopathol; 2018 Nov; 40(6):523-538. PubMed ID: 30206661
[TBL] [Abstract][Full Text] [Related]
10. Diverse functions and mechanisms of regulatory T cell in ischemic stroke.
Wu Y; Li J; Shou J; Zhang W; Chen C
Exp Neurol; 2021 Sep; 343():113782. PubMed ID: 34116055
[TBL] [Abstract][Full Text] [Related]
11. The Role of Mast Cells in Stroke.
Parrella E; Porrini V; Benarese M; Pizzi M
Cells; 2019 May; 8(5):. PubMed ID: 31083342
[TBL] [Abstract][Full Text] [Related]
12. Cerebral stroke injury: the role of cytokines and brain inflammation.
Siniscalchi A; Gallelli L; Malferrari G; Pirritano D; Serra R; Santangelo E; De Sarro G
J Basic Clin Physiol Pharmacol; 2014 May; 25(2):131-7. PubMed ID: 24515999
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between the inflammatory response, sympathetic activation and pulmonary infection in the ischemic stroke.
Winklewski PJ; Radkowski M; Demkow U
J Neuroinflammation; 2014 Dec; 11():213. PubMed ID: 25539803
[TBL] [Abstract][Full Text] [Related]
14. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
Shekhar S; Cunningham MW; Pabbidi MR; Wang S; Booz GW; Fan F
Eur J Pharmacol; 2018 Aug; 833():531-544. PubMed ID: 29935175
[TBL] [Abstract][Full Text] [Related]
15. The Involvement and Therapy Target of Immune Cells After Ischemic Stroke.
Jian Z; Liu R; Zhu X; Smerin D; Zhong Y; Gu L; Fang W; Xiong X
Front Immunol; 2019; 10():2167. PubMed ID: 31572378
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.
Sarvari S; Moakedi F; Hone E; Simpkins JW; Ren X
Metab Brain Dis; 2020 Aug; 35(6):851-868. PubMed ID: 32297170
[TBL] [Abstract][Full Text] [Related]
17. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke.
Neumann J; Riek-Burchardt M; Herz J; Doeppner TR; König R; Hütten H; Etemire E; Männ L; Klingberg A; Fischer T; Görtler MW; Heinze HJ; Reichardt P; Schraven B; Hermann DM; Reymann KG; Gunzer M
Acta Neuropathol; 2015 Feb; 129(2):259-77. PubMed ID: 25391494
[TBL] [Abstract][Full Text] [Related]
18. Brain Immune Interactions-Novel Emerging Options to Treat Acute Ischemic Brain Injury.
Muhammad S; Chaudhry SR; Kahlert UD; Niemelä M; Hänggi D
Cells; 2021 Sep; 10(9):. PubMed ID: 34572077
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 as a Key Mediator of Immune Mechanisms in Ischemic Stroke.
Singh V; Roth S; Veltkamp R; Liesz A
Antioxid Redox Signal; 2016 Apr; 24(12):635-51. PubMed ID: 26493086
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactive Cells After Cerebral Ischemia.
Wang Y; Zhang JH; Sheng J; Shao A
Front Immunol; 2019; 10():2781. PubMed ID: 31849964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
